These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20414014)

  • 21. Screening and treatment for hepatocellular carcinoma.
    Sherman M; Takayama Y
    Gastroenterol Clin North Am; 2004 Sep; 33(3):671-91, xi. PubMed ID: 15324950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
    Conroy T; Gory-Delabaere G; Adenis A; Bosquet L; Bouché O; Louvet C; Mitry E; Bécouarn Y; Bosset JF; Ducreux M; Etienne PL; Merrouche Y; Monges G; Rougier P; ; ; ; ; ; ; ;
    Bull Cancer; 2004 Oct; 91(10):759-68. PubMed ID: 15556876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
    ; ; ; ; ; ; ; ; ;
    J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practical screening and early treatment of hepatocellular carcinoma. Results of a French survey].
    Ganne-Carrié N; Chevret S; Barbare JC; Chaffaud C; Grando V; Vogt AM; Beaugrand M; Trinchet JC;
    Gastroenterol Clin Biol; 2002; 26(6-7):570-7. PubMed ID: 12193855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
    Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
    Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.
    Song P; Tang W; Hasegawa K; Kokudo N
    Drug Discov Ther; 2014 Apr; 8(2):64-70. PubMed ID: 24815580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of hepatocellular carcinoma. Questions for Professor Michel Beaugrand].
    Beaugrand M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):84-6. PubMed ID: 11938047
    [No Abstract]   [Full Text] [Related]  

  • 31. [Advances in recent clinical studies of liver cancer].
    Zhou XD; Tang ZY; Yu YQ
    Zhonghua Wai Ke Za Zhi; 1989 Sep; 27(9):513-8. PubMed ID: 2560960
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatocellular carcinoma: latest developments.
    Walzer N; Kulik LM
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Small hepatocellular carcinoma. Diagnosis and treatment of 40 cases].
    Chen XP
    Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):332-3, 381. PubMed ID: 1337511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
    Alessandrino EP; Amadori S; Barosi G; Cazzola M; Grossi A; Liberato LN; Locatelli F; Marchetti M; Morra E; Rebulla P; Visani G; Tura S;
    Haematologica; 2002 Dec; 87(12):1286-306. PubMed ID: 12495903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of hepatocellular carcinoma.
    El-Serag HB; Marrero JA; Rudolph L; Reddy KR
    Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: overcoming challenges in disease management.
    Gish RG
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):252-61. PubMed ID: 16527686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.